BioDirection’s system, called Tbit, is portable and uses a nanotechnology sensor. The company is betting it will reduce the need for unnecessary CT scans and help patients with head injuries get the correct diagnosis and treatment faster.
This round brings the company’s total funds raised to $10 million, which BioDirection says it will use to speed up the final development stages of Tbit and begin the commercialization process. Provident Healthcare Capital led the round.
More articles on health IT:
10 startups to know for 2016
Harvard startup Gain Life aims to put ‘lifestyle medicine’ on the map
Startup aims to give hospital patients VIP experience
